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1015-9584/Copyright ª 2015, Asian SuSummary Objective: To investigate the clinical application value of intraoperative magnetic
resonance imaging (iMRI) in large invasive pituitary adenoma surgery.
Methods: A total of 30 patients with large pituitary adenoma underwent microscopic tumor
resection under the assistance of an iMRI system; 26 cases received surgery through the
nasaletranssphenoidal approach, and the remaining four cases received surgery through the
pterion approach. iMRI was performed one or two times depending on the need of the surgeon.
If a residual tumor was found, further resection was conducted under iMRI guidance.
Results: iMRI revealed residual tumors in 12 cases, among which nine cases received further
resection. Of these nine cases, iMRI rescanning confirmed complete resection in six cases,
and subtotal resection in the remaining three. Overall, 24 cases of tumor were totally re-
sected, and six cases were subtotally resected. The total resection rate of tumors increased
from 60% to 80%.
Conclusion: iMRI can effectively determine the resection extent of pituitary adenomas. In
addition, it provides an objective basis for real-time judgment of surgical outcome, subse-
quently improving surgical accuracy and safety, and increasing the total tumor resection rate.
Copyright ª 2015, Asian Surgical Association. Published by Elsevier Taiwan LLC. All rights
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The nasal-transsphenoidal approach is the most commonly
used approach in microsurgery for treatment of pituitary
adenoma. However, the operative field of this approach is
small, which makes it impossible to completely discover the
condition of important nerves, cavernous sinus, and the
carotid artery invaded by the tumor, as well as identify the
relationship of the tumor with the hypothalamus. There-
fore, it is difficult to deal with a tumor which has invaded
the aforementioned structures. Because of the lack of
objective test indicators, clinical judgments mainly rely on
the subjective experience and anatomical knowledge of the
surgeon. This increases the chances of a residual tumor,
and at times may even damage the important neuro-
vascular tissues.
In the past decade, intraoperative imaging has become
one of the favored techniques in neurosurgery. Intra-
operative magnetic resonance imaging (iMRI) is the most
advanced means of intraoperative imaging. As a good
adjunct to neurosurgery, iMRI can provide a more objective
assessment for controlling the intraoperative quality,1e6 and
effectively determining the resection level of a tumor and
the relationship of the lesion with surrounding functional
tissues.7,8 Several reports have pointed out that iMRI iden-
tifies residual tumors in approximately 30% of the cases in
which the surgeons believed that the tumors were totally
resected.5,8 iMRI is helpful in observing and discovering the
residual tumor invading the parasellar structures and
cavernous sinus.9e12 Application of iMRI to the treatment of
pituitary adenoma for achievingmaximal tumor removal and
minimal damage to surrounding normal functional tissues is
seldom reported. In this study, 30 patientswith large invasive
pituitary adenoma received surgery under the assistance of
iMRI. We aimed to investigate the clinical application value
of iMRI in large invasive pituitary adenoma surgery.
2. Patients and methods
2.1. Patients
A total of 30 patients (13 men and 17 women) were enrolled
in this study. The patientswere aged 21e65 years (mean age,
36 years). Of these 30 patients, pituitary adenomawas found
for the first time in 26 patients, whereas the remaining four
patients suffered from postoperative recurrence or residual
pituitary adenoma. There were 22 cases of headache, 26
cases of visual disturbance, four cases of galactorrhea, seven
cases of menstrual irregularity or menopause, eight cases of
acromegaly, and nine cases of declining sexual function. This
study was conducted with approval from the Ethics Com-
mittee of Jinling Hospital, School of Medicine, Nanjing Uni-
versity (Nanjing, China). Written informed consent was
obtained from all patients or their families.
2.2. Imaging, endocrinological, and pathological
examinations
Head computed tomography (CT), MRI, and endocrinolog-
ical, routine pathological, and immunohistochemicalexaminations were performed on all patients. The
maximum tumor diameter was 18e65 mm (30 mm in 10
cases; 31e50 mm in 17 cases; and 50 mm in three cases).
Based on preoperative tumor morphology identified on
magnetic resonance images, the tumors were classified
according to the KnospeSteiner carotid arterial line clas-
sification: consequently, 16 cases were diagnosed as inva-
sive pituitary adenoma, and the remaining 14 cases as
noninvasive pituitary adenoma. According to clinical man-
ifestations and endocrinological and pathological exami-
nation results, nine, four, eight, and nine cases were
diagnosed as nonfunctioning pituitary adenoma, prolactin-
secreting pituitary adenoma, growth hormone-secreting
pituitary adenoma, and gonadal hormone-secreting ade-
noma, respectively.
2.3. Surgery and iMRI examination
All 30 patients received general anesthesia prior to micro-
scopic tumor resection under the assistance of an iMRI
system; 26 cases received surgery through the nasal-
etranssphenoidal approach, and the remaining four cases
received surgery through the pterion approach. For the iMRI
examination, the patients lay in a suitable position, and
were fixed with a titanium head frame. The incision was
made based on tumor size and invasive-growth direction
identified on preoperative MRI. The surgical procedure was
basically the same as that of conventional microsurgery.
The iMRI system used a 1.5-T superconducting magnet
(MAGNETOM Espree; Siemens Healthcare, PA, USA), with
dual-chamber design, namely, an operating room and a
diagnostic room, which were separated by a metal screen
door. If no iMRI was performed, the MRI magnet was in the
diagnostic room. When iMRI was needed, the screen door
was opened, and the patient was brought into the diag-
nostic room and placed on a long bed that slides into the
MRI chamber. After completion of iMRI, the patient was
shifted back to the operating room. Based on the needs of
the surgeon, the iMRI was performed one or two times to
understand the extent of tumor resection required. If the
iMRI revealed a residual tumor, further resection was car-
ried out under iMRI guidance. The scanning was repeated
until complete tumor resection was confirmed by iMRI.
3. Results
3.1. Extent of tumor resection
The extent of tumor resection needed was determined by
iMRI examination. Residual tumor was identified in 12
cases, among which nine cases required further resection.
We did not perform further resection in the remaining three
cases because the tumor had extensively invaded the
cavernous sinus, sphenoid sinus, and clivus, with hard or
tough texture, and the extent of resection had reached the
preoperative expectation. Among the nine cases that
required further resection, iMRI rescanning confirmed
complete resection in six cases, and subtotal resection in
the remaining three (the tumor invaded the cavernous sinus
and surrounded the carotid artery, and the resection range
had achieved the expectation). Overall, 24 cases achieved
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resection. The complete tumor resection rate increased
from 60% to 80% (Figs. 1 and 2).
3.2. Pituitary hormone change
The pituitary hormone level of all patients was rechecked 7
days later. In eight cases with growth hormone-secreting
pituitary adenoma, the growth hormone level was reduced
to normal in six cases, and in the remaining two cases, it
had decreased by >50%. In four cases with prolactin-Figure 1 Resection of a large invasive pituitary adenoma under
(iMRI) using the nasal-transsphenoidal approach.secreting pituitary adenoma, the prolactin level was
reduced to normal in two cases, with a >50% decrease.
There was a <50% decrease in the other two cases.
3.3. Postoperative complications
After the surgery, diabetes insipidus occurred in three pa-
tients, which disappeared after 1e2 weeks of pituitary
hormone therapy. Cerebrospinal fluid rhinorrhea occurred
in four cases, which was cured by continuous lumbar
drainage of cerebrospinal fluid for 1 week. Suprasellarthe assistance of intraoperative magnetic resonance imaging
Figure 2 Resection of a recurred large invasive pituitary adenoma under the assistance of intraoperative magnetic resonance
imaging (iMRI) using the pterion approach.
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one case. However, the postoperative head CT demon-
strated that the suprasellar cistern subarachnoid hemor-
rhage did not increase, and there was no decreased visual
acuity. After continuous lumbar drainage of cerebrospinal
fluid for 1 week, the headache symptom was mitigated, and
the patient was discharged with good recovery. The iMRI
was performed one or two times, which extended the total
time of surgery to approximately 1 hour, but there was no
iMRI-associated secondary infection or adverse event. The
mean duration of hospitalization was 12 days.
3.4. Follow up
Postoperative follow up was performed on 30 patients by
outpatient review or telephone interview. The follow-up
time was 3e24 months. In 22 cases of preoperative head-
ache, the symptom disappeared in 13 patients, and was
significantly mitigated in the other nine cases. The visual
disturbance was ameliorated in 22 cases, and acromegaly
was ameliorated in six cases. Galactorrhea stopped in two
cases, and there was recovery of the menstrual cycle. Pa-
tients with a residual tumor or pituitary hormone abnor-
malities were treated by radiation or medical therapy, and
had satisfactory results.4. Discussion
4.1. Necessity of iMRI in pituitary adenoma surgery
In treatment of pituitary adenoma, the nasaletrans-
sphenoidal approach has been widely used, because it can
shorten the operation path, reduce the surgical trauma,
and avoid the exposure and stretch of brain tissues. How-
ever, this approach has a small operative field and there is
disturbance due to the “blind field”. Thus, the surgeons
cannot completely remove the tumors under direct vision.
Therefore, the outcome of resection is often subjective,
which increases the chances of residual tumor. The pter-
ional approach is the most widely used procedure in
transcranial pituitary adenoma surgery. This approach is
applicable to the suprasellar-extended tumor, dumbbell-
shaped huge tumor, and invasive tumor extending to the
parasellar and postsellar regions and anterior skull base. In
craniotomy, the region among the ipsilateral optic nerve,
optic tract bottom, and interior of the clinoid process of
the ipsilateral internal carotid artery is the “blind field.”
The tumors in the ipsilateral optic nerve bottom and lateral
walls of the cavernous sinus are often invasive tumors, and
thus the explosion of tumor and resection of these tumors is
difficult. In addition, the tumors in the sellar region and
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due to visual limitations. Therefore, the surgical process
and outcome mainly depends on surgeons’ subjective
experience, and there is a lack of objective detection in-
dicators and basis.
The aforementioned problems can best be solved by
making use of real-time intraoperative imaging technology.
In the mid-1990s, with the development of hardware and
software of MRI technology, Black et al1 pioneered the
introduction of MRI technology in neurosurgery. In 1995, the
Department of Neurosurgery of Erlangen and Heidelberg
University, in cooperation with Siemens Company, devel-
oped the first iMRI system.13 The combination of iMRI
technology and neurosurgery not only possesses the three-
dimensional positioning function, but also has the real-time
navigation function, which effectively assists the surgeon to
identify and resect the diseased tissue accurately, while
avoiding damage to the major blood vessels, nerves, or
functional areas of the brain. This technology has enabled
real-time judgment and objective evaluation of the results
of surgery. Therefore, iMRI can greatly improve the accu-
racy, safety, and objectivity of neurosurgery, and has
important clinical significance for improving the quality of
surgery.
In general, according to magnetic-field strength, the
iMRI system is divided into low-field strength (<0.5 T) and
high-field strength (1.5 T). The high-field-magnet iMRI
system can be further divided into the fixed magnet type
and the movable magnet type, based on whether the
magnet can be moved or not.14,15 The magnet of the former
is fixed, and the patient is moved into the magnet through a
movable bed; by contrast, in the latter case, the patient is
fixed, and the magnet is shifted to the operating room for
scanning. Our hospital introduced the German Siemens
fixed magnet-rotating bed high-field (1.5 T) iMRI system.4.2. Role of iMRI in pituitary adenoma surgery
Wirtz et al16 reported that iMRI scanning revealed residual
tumors in 62.1% of high-grade glioma patients and in 41.4%
of low-grade glioma patients. Nimsky et al5 also reported
that among 48 patients who received complete pituitary
tumor resection, iMRI discovered 19 cases (39.6%) of re-
sidual tumors that needed further resection. With the
assistance of iMRI, the total resection rate of tumors
increased from 56.2% to 87.5%. In our study, with the
assistance of iMRI, the complete tumor resection rate
increased from 60% to 80%, suggesting that iMRI could
significantly increase the total resection rate of pituitary
adenoma.
Large invasive pituitary adenoma is bulky and often
develops toward the lateral, posterior, superior, or anterior
part of the sella. It involves a variety of neurovascular
structures, which increases the difficulty of surgery and
postoperative complications. Although the transsphenoidal
and pterional approaches are very mature, it is still difficult
to completely resect large invasive pituitary adenomas due
to the visual limitations. iMRI can provide three-
dimensional stereoscopic images, which allow the surgeon
to observe the relationship and distance between a pitui-
tary tumor and important structures.17e19 Therefore, thesurgeon can resect the tumor as much as possible while
ensuring the safety of surgery, thereby avoiding damage to
the important blood vessels and nerves around the sella
turcica.
iMRI offers real-time surgical evaluation, which enables
surgeons to identify acute surgical complications and
reduce postoperative complications. In this study, iMRI
identified a case of suprasellar cistern subarachnoid hem-
orrhage when operating using the transsphenoidal
approach. The postoperative head CT demonstrated no
increase of subarachnoid hemorrhage in this patient. The
patient had postoperative headache without vision loss.
After continuous drainage of blood cerebrospinal fluid by
lumbar puncture for 1 week, the symptoms were mitigated,
and the patient had good recovery.
Whether the iMRI system extends the operation time or
not is a controversial issue. The movement of patients and
their preparation in the operating room before and after
scanning takes some time. It needs approximately 20 mi-
nutes to complete intraoperative routine scanning with the
1.5-T magnet, and the movement of the patient and
preparation requires 5 minutes. Thus, one intraoperative
scan can be completed within 25 minutes, which is an
acceptable duration. The applications of iMRI and func-
tional neural navigation enable the surgeon to better
distinguish between the tumor border and important brain
functional structures, and thus resect the lesions much
more quickly, which saves on operation time. In addition,
iMRI can actually reduce the total medical costs by reducing
the risk of complications, secondary surgery, and average
hospitalization duration (although its actual operation time
is longer than the traditional surgery).20 In this study, iMRI
scanning was performed one or two times, which extended
the total surgery time to approximately 1 hour; however,
none of the patients had iMRI-associated secondary infec-
tion and adverse events caused by secondary surgery and
magnetic fields. The average length of hospital stay and
total medical costs also did not increase.4.3. Prospect of iMRI
With the continuous development of iMRI technology, it is
possible that iMRI could be combined with many other
technologies such as laser, endoscopy, focused ultrasound,
freezing, radiofrequency ablation, and intraoperative brain
functional evaluation. Endoscopic operating direction and
depth can be freely controlled using a multiangle lens,
which can make up for the restrictions of single tubular
vision in surgical microscopes and benefit the tumor
resection.21 In this study, iMRI revealed residual tumors in
three cases of invasive pituitary adenoma. After further
resection of the tumor using neuroendoscopic procedures,
iMRI rescanning showed complete tumor resection. The
results suggest that iMRI could be combined with endo-
scopic techniques to improve the resection extent of pitu-
itary adenoma.
At present, iMRI is a new technology with continuous
development. With increasingly growing interest in its
application and a higher rate of acceptance by neurosur-
geons, the integration of iMRI with traditional neurosurgery
will offer a wide range of application. iMRI technology
iMRI in pituitary adenoma surgery 173provides the neurosurgeon with real-time guidance and
real-time objective evaluation of surgical outcomes,
thereby enhancing the accuracy and safety of neurosur-
gery, and thus increasing the degree of tumor resection.
However, iMRI has some limitations such as high cost, loud
noise, radiofrequency pulse-energy accumulation in body,
and increased metal artifacts. These issues need to be
addressed in further development and application.
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